GeneReach Biotechnology Market Cap

GeneReach Biotechnology has a market cap or net worth of 1.15 billion as of July 15, 2025. Its market cap has decreased by -41.26% in one year.

Market Cap

1.15B

Enterprise Value

965.63M

Revenue

213.05M

Ranking

n/a

PE Ratio

n/a

Stock Price

20.10

Market Cap Chart

Since November 19, 2012, GeneReach Biotechnology's market cap has decreased from 1.27B to 1.15B, a decrease of -9.70%. That is a compound annual growth rate of -0.80%.

Market Cap History

Date	Market Cap	% Change
Jul 14, 2025	1.15B	-30.19%
Dec 31, 2024	1.65B	-27.38%
Dec 29, 2023	2.27B	-25.28%
Dec 30, 2022	3.03B	-20.04%
Dec 30, 2021	3.79B	-27.82%
Dec 31, 2020	5.26B	91.85%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	188.45B
PharmaEssentia	178.63B
Bora Pharmaceuticals Co., LTD.	86.16B
Lotus Pharmaceutical	56.28B
Polaris Group	29.31B
Oneness Biotech	29.27B
Center Laboratories	26.92B
Pegavision	23.75B

Market Cap Rankings